Author

Koji Iwato

Observed names: Iwato, Koji, K Iwato, K. Iwato, KOJI IWATO, Koji IWATO, 岩戸,康治

Observed institutions: Hiroshima University, Tokai University, Kyoto University, Kurashiki Central Hospital, Hamanomachi Hospital, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Tokai University Hospital, Anjo Kosei Hospital, Toranomon Hospital, The University of Osaka

ORCID: 0000-0002-9105-8632

Observed ORCID: 0000-0002-9105-8632

OpenAlex ID: A5063560052

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1988 · Michio Kawano, Toshio Hirano, et al. · Nature · 1,632

Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma

1989 · M Kawano, I Yamamoto, et al. · Blood · 122

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

2011 · Yukari Shirasugi, Kiyoshi Ando, et al. · International Journal of Hematology · 108

Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation

2014 · H Nakasone, T Fukuda, et al. · Bone Marrow Transplantation · 75

Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients

2017 · Masamitsu Yanada, Jinichi Mori, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 70

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

2019 · Yasuyuki Arai, Tadakazu Kondo, et al. · Blood Advances · 69

PDF

Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia

2016 · Moe Kadono, Akinori Kanai, et al. · Experimental Hematology · 64

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

2004 · Y Kanda, K Izutsu, et al. · Leukemia · 64

2011 · Junya Kanda, Hiroh Saji, et al. · Blood · 62

Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.

1989 · I Yamamoto, M Kawano, et al. · PubMed · 62

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

2016 · M Kato, T Yamashita, et al. · Leukemia · 60

Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan

2004 · M Yanada, N Emi, et al. · Bone Marrow Transplantation · 59

Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia

2015 · Jun Aoki, Heiwa Kanamori, et al. · American Journal of Hematology · 57

PDF

Impact of a single human leucocyte antigen ( HLA ) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA W orking G roup of the J apan S ociety for B lood and M arrow T ransplantation

2013 · Yoshinobu Kanda, Junya Kanda, et al. · British Journal of Haematology · 56

Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

2010 · Satoshi Nishiwaki, Yoshihiro Inamoto, et al. · Blood · 52

PDF

Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older

2017 · Koji Kawamura, Shinichi Kako, et al. · Transplantation and Cellular Therapy · 46

PDF

Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors

2013 · Makoto Hirokawa, Takahiro Fukuda, et al. · Transplantation and Cellular Therapy · 46

PDF

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System Involvement

2014 · Jun Aoki, Ken Ishiyama, et al. · Transplantation and Cellular Therapy · 39

PDF

An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)

2012 · Yukari Shirasugi, Kiyoshi Ando, et al. · International Journal of Hematology · 39

HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR

2020 · Kazuya Sakai, Masataka Kuwana, et al. · Blood · 38

PDF

A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura

2009 · Yukari Shirasugi, Kiyoshi Ando, et al. · International Journal of Hematology · 38

Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells

2008 · Masaharu Nobuyoshi, Michio Kawano, et al. · British Journal of Haematology · 38

Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation

2014 · Junya Kanda, Tatsuo Ichinohe, et al. · Transplantation and Cellular Therapy · 37

PDF

Five Cases of Anthracycline-Induced Cardiomyopathy Effectively Treated with Carvedilol

2004 · Yasushi MUKAI, Tomoki YOSHIDA, et al. · Internal Medicine · 37

PDF

Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan

2017 · Hidehiro Itonaga, Kazunari Aoki, et al. · Transplantation and Cellular Therapy · 34

PDF

Works count: 129

Citation count: 3,852

H-index: 30

I10-index: 59